🇺🇸 Glargine Basal-Bolus Therapy in United States

Glargine Basal-Bolus Therapy (Glargine Basal-Bolus Therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Glargine Basal-Bolus Therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Glargine Basal-Bolus Therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Glargine Basal-Bolus Therapy in United States?

Eli Lilly and Company is the originator. The local marketing authorisation holder may differ — check the official source linked above.